24-Norursodeoxycholic acid
Nor-UDCA, a side chain-shortened derivative of ursodeoxycholic acid (UDCA), exhibits enhanced anti-cholestatic, anti-inflammatory, and anti-fibrotic activities. It demonstrates superior efficacy to UDCA in murine models of sclerosing cholangitis, such as Mdr2 knockout mice, making it a valuable research tool for investigating cholestatic liver diseases.
Product Specifications
CAS Number
99697-24-2
Product Name Alternative
Inhibit, Norucholic acid, nor-UDCA, Inhibitor, 24 Norursodeoxycholic acid, 24Norursodeoxycholic acid, 24-Norursodeoxycholic acid
Purity
99.69% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween 80+45% Saline:4 mg/mL (10.57 mM) ; DMSO:100 mg/mL (264.17 mM)
Smiles
[H][C@@]12CC[C@H] ([C@H] (C) CC (O) =O) [C@@]1 (C) CC[C@@]1 ([H]) [C@@]2 ([H]) [C@@H] (O) C[C@]2 ([H]) C[C@H] (O) CC[C@]12C
Molecular Formula
C23H38O4
Molecular Weight
378.55
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Monoclonal Antibody to Epidermal Growth Factor Receptor (EGFR)
Monoclonal Antibody to Epidermal Growth Factor Receptor (EGFR)
Monoclonal Antibody to Epidermal Growth Factor Receptor (EGFR)
Monoclonal Antibody to Epidermal Growth Factor Receptor (EGFR)